As discussed, HLXB9 can play a significant role in tumor progression, the GSK-3β phosphorylates and stabilizes the HLXB9 protein and, therefore, can be targeted to control the development of insulinomas (Desai et al., 2014). Here, MNX1 is linked to neoplasm.